Literature DB >> 23312843

Regulation and dysregulation of 3'UTR-mediated translational control.

Jie Jia1, Peng Yao, Abul Arif, Paul L Fox.   

Abstract

Translational control provides numerous advantages in regulation of gene expression including rapid responsiveness, intracellular localization, nondestruction of template mRNA, and coordinated regulation of transcript ensembles. Transcript-selective, translational control is driven by the specific interaction of factor(s) with the 5' or 3' untranslated region (UTR), thereby influencing initiation, elongation, or termination of mRNA translation. The mean length of human 3'UTRs is greater than that of 5'UTR, indicating the expanded potential for motifs, structural elements, and binding sites for trans-acting factors that exert transcript-selective translation control. New and unexpected mechanisms of 3'UTR-mediated translational control and their contributions to disease have received increasing attention during the last decade. Here, we briefly review a few recent and representative discoveries of 3'UTR-mediated translational control, emphasizing the novel aspects of these regulatory mechanisms and their potential pathophysiological significance.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23312843      PMCID: PMC3644486          DOI: 10.1016/j.gde.2012.12.004

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  38 in total

Review 1.  Translational control by the 3'-UTR: the ends specify the means.

Authors:  Barsanjit Mazumder; Vasudevan Seshadri; Paul L Fox
Journal:  Trends Biochem Sci       Date:  2003-02       Impact factor: 13.807

Review 2.  Oncogene addiction.

Authors:  I Bernard Weinstein; Andrew Joe
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

Review 3.  The biology of vascular endothelial growth factors.

Authors:  Tuomas Tammela; Berndt Enholm; Kari Alitalo; Karri Paavonen
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

4.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

Authors:  Pedro P Medina; Mona Nolde; Frank J Slack
Journal:  Nature       Date:  2010-08-08       Impact factor: 49.962

5.  DAPK-ZIPK-L13a axis constitutes a negative-feedback module regulating inflammatory gene expression.

Authors:  Rupak Mukhopadhyay; Partho Sarothi Ray; Abul Arif; Anna K Brady; Michael Kinter; Paul L Fox
Journal:  Mol Cell       Date:  2008-11-07       Impact factor: 17.970

6.  A post-transcriptional pathway represses monocyte VEGF-A expression and angiogenic activity.

Authors:  Partho Sarothi Ray; Paul L Fox
Journal:  EMBO J       Date:  2007-07-05       Impact factor: 11.598

7.  A stress-responsive RNA switch regulates VEGFA expression.

Authors:  Partho Sarothi Ray; Jie Jia; Peng Yao; Mithu Majumder; Maria Hatzoglou; Paul L Fox
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

8.  MicroRNAs and cancer: short RNAs go a long way.

Authors:  Andrea Ventura; Tyler Jacks
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

9.  Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis.

Authors:  Christian Stockmann; Andrew Doedens; Alexander Weidemann; Na Zhang; Norihiko Takeda; Joshua I Greenberg; David A Cheresh; Randall S Johnson
Journal:  Nature       Date:  2008-11-09       Impact factor: 49.962

Review 10.  Mechanisms of adverse effects of anti-VEGF therapy for cancer.

Authors:  T Kamba; D M McDonald
Journal:  Br J Cancer       Date:  2007-05-22       Impact factor: 7.640

View more
  51 in total

1.  Formation of chimeric genes by copy-number variation as a mutational mechanism in schizophrenia.

Authors:  Caitlin Rippey; Tom Walsh; Suleyman Gulsuner; Matt Brodsky; Alex S Nord; Molly Gasperini; Sarah Pierce; Cailyn Spurrell; Bradley P Coe; Niklas Krumm; Ming K Lee; Jonathan Sebat; Jon M McClellan; Mary-Claire King
Journal:  Am J Hum Genet       Date:  2013-10-03       Impact factor: 11.025

2.  The SNAI1 3'UTR functions as a sponge for multiple migration-/invasion-related microRNAs.

Authors:  Jun Li; Hailin Yu; Meili Xi; Duan Ma; Xin Lu
Journal:  Tumour Biol       Date:  2014-10-19

Review 3.  Translational control mechanisms in angiogenesis and vascular biology.

Authors:  Peng Yao; Sandeepa M Eswarappa; Paul L Fox
Journal:  Curr Atheroscler Rep       Date:  2015-05       Impact factor: 5.113

4.  Methylxanthines Increase Expression of the Splicing Factor SRSF2 by Regulating Multiple Post-transcriptional Mechanisms.

Authors:  Jia Shi; Kirk Pabon; Kathleen W Scotto
Journal:  J Biol Chem       Date:  2015-03-28       Impact factor: 5.157

Review 5.  A tour through the transcriptional landscape of platelets.

Authors:  Sebastian Schubert; Andrew S Weyrich; Jesse W Rowley
Journal:  Blood       Date:  2014-06-05       Impact factor: 22.113

Review 6.  Alternative polyadenylation in the nervous system: to what lengths will 3' UTR extensions take us?

Authors:  Pedro Miura; Piero Sanfilippo; Sol Shenker; Eric C Lai
Journal:  Bioessays       Date:  2014-06-05       Impact factor: 4.345

7.  RNA-binding protein hnRNPLL regulates mRNA splicing and stability during B-cell to plasma-cell differentiation.

Authors:  Xing Chang; Bin Li; Anjana Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

8.  Major splice variants and multiple polyadenylation site utilization in mRNAs encoding human translation initiation factors eIF4E1 and eIF4E3 regulate the translational regulators?

Authors:  Silvia Mrvová; Klára Frydrýšková; Martin Pospíšek; Václav Vopálenský; Tomáš Mašek
Journal:  Mol Genet Genomics       Date:  2017-09-23       Impact factor: 3.291

Review 9.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

Review 10.  The Growing Toolbox for Protein Synthesis Studies.

Authors:  Shintaro Iwasaki; Nicholas T Ingolia
Journal:  Trends Biochem Sci       Date:  2017-05-28       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.